A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
The UCLA Jonsson Comprehensive Cancer Center has established an international reputation for providing the best in experimental and traditional cancer treatments and expertly guiding the next generation of medical research.
Santa Monica, California Clinical Trial Location
UCLA Hematology/Oncology – Santa Monica
2336 Santa Monica Blvd #301,
Santa Monica, CA 90404